PetMed Express, Inc. (PETS)
3.32
0.00 (0.00%)
USD |
NASDAQ |
Jan 09, 16:00
3.31
-0.01
(-0.30%)
After-Hours: 20:00
PetMed Express EPS Diluted (Quarterly): -0.4079 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| CDT Equity, Inc. | -13.16 |
| LENZ Therapeutics, Inc. | -0.5851 |
| Liminatus Pharma, Inc. | -0.0675 |
| Oruka Therapeutics, Inc. | -0.6871 |
| Maze Therapeutics, Inc. | -0.6258 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -8.52M |
| Revenue (Quarterly) | 44.36M |
| Total Expenses (Quarterly) | 52.88M |
| Enterprise Value | 35.63M |
| Gross Profit Margin (Quarterly) | 22.85% |
| Profit Margin (Quarterly) | -19.20% |
| Earnings Yield | -79.86% |
| Normalized Earnings Yield | -49.39 |